Find out if Ozempic® or Mounjaro® is right for you

A 60-second assessment, reviewed by doctors, to check your eligibility for GLP-1 medication and the results you may expect.

✓Personalised eligibility review

✓Estimated weight-loss outcomes

✓Reviewed by a consultant endocrinologist (MRCP, UK)

Trusted by patients across India

60 seconds · Private · No obligation

Ozempic® and Mounjaro® are registered trademarks of their respective owners. ALTRcare is not affiliated with Novo Nordisk or Eli Lilly.